Actively Recruiting
Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
Led by AC Camargo Cancer Center · Updated on 2025-12-16
84
Participants Needed
1
Research Sites
49 weeks
Total Duration
On this page
Sponsors
A
AC Camargo Cancer Center
Lead Sponsor
H
Hospital do Cancer de Londrina
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective of this randomized clinical trial is to assess whether the use of surgical gloves during treatment can prevent the occurrence of oxaliplatin-induced peripheral neuropathy.
CONDITIONS
Official Title
Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older who have provided written informed consent.
- Diagnosis of colon adenocarcinoma at high-risk stage III (pT4pN2) or stage IV.
- Receiving oxaliplatin-based chemotherapy for localized or metastatic disease.
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-1.
You will not qualify if you...
- Presence of pre-existing neuropathy.
- Uncontrolled diabetes.
- Known allergies to gloves.
- Prior treatment with paclitaxel, docetaxel, or oxaliplatin.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
A.C. Camargo Cancer Center
São Paulo, São Paulo, Brazil
Actively Recruiting
Research Team
V
Virgilio Souza Silva, Medical Doctor, PhD
CONTACT
É
Éverton Germano Melo, Medical Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here